The scale of the problem is striking. Adolescents and young adults, typically defined as patients diagnosed between roughly 15 and 39 years of age, represent a growing survivor population, and so do adults who were treated for cancer as children. Both groups now live for decades after their diagnoses, thanks to dramatic improvements in oncology care. But longevity brings chronic health conditions, ongoing surveillance, and repeated interactions with an expensive health care system. The review positions financial hardship alongside cardiac dysfunction, secondary cancers, and other well-known late effects, arguing that it deserves the same clinical attention because it directly undermines quality of life and deepens health inequities.

The drivers of financial hardship in these populations are distinctive. High out-of-pocket medical costs top the list, and studies cited in the review show that survivors of adolescent and young adult cancers carry additional medical expenditures linked to chronic conditions and psychological distress compared with peers who never had cancer. French cohort studies of long-term pediatric solid tumor survivors documented excess health care expenditures persisting well into adulthood. In the United States, analyses from the Childhood Cancer Survivor Study found that even after the Affordable Care Act expanded insurance coverage, substantial numbers of adult survivors of childhood cancer continued to report material hardship, including difficulty paying bills, skipped payments, and food insecurity.

Employment disruption compounds the damage. Young survivors are at a life stage when careers, savings, and independence are supposed to be built, yet cancer interrupts education and derails workforce entry. The review highlights evidence of job lock, a phenomenon in which survivors remain in unsuitable or lower-paying jobs simply to keep employer-sponsored health insurance. A meta-analysis dating back to 2006 already showed elevated unemployment among adult survivors of childhood cancer, and more recent work from the Childhood Cancer Survivor Study linked chronic health conditions to longitudinal employment losses, with productivity losses among these survivors estimated to impose an annual economic burden in the billions of dollars nationally.

Fertility preservation adds another layer of financial strain that is largely unique to young patients. Gonadotoxic therapies threaten future fertility, and guidelines recommend discussing preservation options before treatment begins. But sperm banking, egg freezing, and embryo cryopreservation are expensive, insurance coverage is inconsistent, and only a patchwork of state laws mandates coverage. Qualitative studies and social media analyses cited in the review show that cost frequently shapes whether young patients pursue preservation at all, turning a deeply personal reproductive decision into a financial one. Female survivors who pursued fertility preservation reported greater subsequent financial hardship, illustrating how a single early decision can echo across years of survivorship.

The burden is not distributed evenly. The review identifies racial and ethnic minorities, LGBTQIA+ individuals, and rural residents as facing disproportionate risk. A cross-sectional study of adolescent and young adult survivors in Kentucky documented racial and rural disparities in financial toxicity and in the transitions between pediatric and adult health care. Research during the COVID-19 pandemic found that LGBTQIA+ young survivors experienced compounded financial burden and worse mental health, while pandemic-related employment disruptions hit young adult survivors particularly hard because many worked in vulnerable sectors. Neighborhood socioeconomic disadvantage also correlates with financial hardship among long-term childhood cancer survivors, suggesting that structural factors beyond the clinic shape who pays the steepest price.

The consequences extend well beyond bank accounts. Financial hardship is linked to treatment non-adherence, delayed follow-up care, and adverse psychosocial outcomes. Survivors worried about money may skip surveillance mammograms, echocardiograms, or endocrine checks precisely when early detection of late effects matters most. Emerging evidence presented at the American Society of Clinical Oncology annual meeting and cited in the review connects financial hardship among childhood cancer survivors to non-adherence with both lifestyle recommendations and surveillance protocols. Psychological dimensions, including anxiety about daily financial needs, depression, and fear of cancer recurrence, intertwine with material hardship, and caregivers and family members absorb part of the distress through their own financial and emotional sacrifices.

Care transitions and insurance changes act as danger points where hardship can spike. Survivors moving from pediatric to adult care often lose coordinated support, and young adults aging off parental insurance plans face coverage cliffs at exactly the moment long-term surveillance needs intensify. Studies of hematopoietic cell transplant survivors, a group with intensive long-term needs, found pronounced age and gender differences in financial distress. Meanwhile, Medicaid expansion has changed enrollment patterns among childhood cancer survivors, and research is ongoing into how such policy shifts affect screening adherence, including cardiomyopathy monitoring among Medicaid-enrolled survivors.

Interventions remain limited but are beginning to take shape. The review highlights early financial risk screening at diagnosis, the integration of financial navigation into oncology and survivorship care, and educational programs that teach survivors about insurance. Pilot studies of oncology financial navigation programs, financial toxicity screening implementations, and health insurance navigation tools tested within the Childhood Cancer Survivor Study suggest that structured support can reduce distress and improve coverage decisions. One-time financial grants have shown early promise for young adult survivors, and digital tools, including social media peer support and online resource delivery, offer scalable ways to reach survivors who live far from specialized centers. European Society for Medical Oncology consensus statements now call for systematic screening and management of financial toxicity, signaling growing international recognition of the problem.

The authors conclude that significant gaps persist. Prospective, population-based research is scarce; most evidence is cross-sectional and skewed toward survivors engaged with academic health systems. Culturally tailored interventions for underserved survivors are largely absent, and systematic inclusion of racial minorities, rural residents, and LGBTQIA+ survivors in intervention trials remains rare. The review’s central message is that solving financial hardship will require coordinated clinical, policy, and community action: clinics must screen and navigate, insurers and lawmakers must decouple coverage from employment and expand fertility preservation benefits, and communities must support survivors who fall through the cracks. Until then, financial toxicity will remain a silent late effect, shaping the lives of young cancer survivors long after their treatment ends.

Subject of Research: Financial hardship and financial toxicity among adolescent and young adult cancer survivors and adult survivors of childhood cancer

Article Title: Financial hardship in adolescent and young adult cancer survivors and adult survivors of childhood cancers

Article References: Garg, A., Monick, S., Kimball, B., Bhatt, N. S., Khera, N., & Rosenthal, A. (2026). Financial hardship in adolescent and young adult cancer survivors and adult survivors of childhood cancers. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-026-02133-y

Image Credits: AI Generated

DOI: 10.1007/s11764-026-02133-y

Keywords: financial toxicity, cancer survivors, adolescent and young adult oncology, childhood cancer survivors, health equity, survivorship care, employment disruption, fertility preservation, health insurance, financial navigation, late effects, health disparities

The research, conducted by Jean C. Yi, Sheri Ballard, Emily Jo Artim, Casey Walsh, and K. Scott Baker at Fred Hutchinson Cancer Center, took a mixed methods approach, combining hard utilization data from the electronic health record with in-depth qualitative interviews. All participants were one to five years past the end of cancer treatment, a window when survivorship care is considered especially critical. The team queried the electronic health record to determine which survivors had been seen in the Survivorship Clinic, then conducted qualitative interviews with a randomly selected subset of participants drawn from a larger parent study testing a digital health intervention. That parent trial, known as INSPIRE—the INteractive survivorship program to improve health care REsources—is designed to test a digital intervention with stepped care telehealth to improve outcomes for adolescent and young adult survivors.

The demographic profile of the small group that did use the clinic was telling. Among the 38 clinic users, 86.8 percent were female, 71.1 percent were White, 86.8 percent were not Hispanic, and 65.7 percent had been treated for breast cancer. This skew toward female, White, and breast cancer populations raises questions about equitable reach, though the study’s primary focus was on understanding why utilization was so low across the board. The picture that emerged from the electronic health record was unambiguous: survivorship services, even when available at the very institution where these patients had been treated, were being used by fewer than one survivor in twenty.

To understand the reasons behind those numbers, the researchers screened a subset of 147 participants enrolled in the parent trial for approach to qualitative interviews, ultimately completing forty interviews. The interviewees had a mean age of 38.4 years, with half having had breast cancer; 78 percent were female, 83 percent were White, and 92 percent had attained a college degree or higher education. Despite being well educated and demographically similar to the clinic-using group, only one of the forty interview participants had ever visited the Survivorship Clinic. That single data point may be the most arresting in the study: even among survivors engaged enough to enroll in a survivorship research trial, virtually none had accessed the clinic down the hall.

Through content analysis of the interview transcripts, the researchers identified a set of barriers that fell into distinct but interconnected categories. The most significant was simple lack of awareness: many survivors simply did not know the survivorship clinic existed or what services it offered. This was compounded by avoidance—a psychological reluctance to confront cancer again after treatment had ended—and by lack of time, as young adults juggle careers, education, caregiving responsibilities, and the reestablishment of normal life. For a population at the busiest and most transitional stage of adulthood, an additional medical appointment that they had never heard of and did not fully understand carried little apparent urgency.

The interviews also illuminated what would have made a difference. Participants identified referrals from their oncology care teams, concrete information about the services the clinic provides, and the availability of telehealth as factors that would have facilitated them seeking survivorship care. In other words, the barriers were not primarily about motivation or health literacy alone; they were structural and communicative. Survivors needed a trusted clinician to tell them, at the end of treatment, that a survivorship clinic exists and why it matters. They needed to know what would happen during a visit—what late effects would be screened, what symptoms could be addressed, what psychosocial support was available. And they needed flexible access options compatible with the realities of young adult life, including remote participation.

The study arrives at a moment when survivorship care is being formalized at the national level. The National Standards for Cancer Survivorship Care propose health system policies to develop survivorship programs, and the National Comprehensive Cancer Network’s survivorship guidelines, updated in 2025, call for structured follow-up care including survivorship care plans. Yet this research shows that the existence of a clinic, even within a comprehensive cancer center, does not guarantee uptake. Prior work has documented low attendance among childhood cancer survivors and among Hodgkin lymphoma survivors, and studies of rural childhood cancer survivors have similarly pointed to awareness and access as limiting factors. The new study extends that evidence into the adolescent and young adult population, which is demographically and clinically distinct from both pediatric and older adult populations.

That distinctiveness is part of why the gap matters so much. Adolescents and young adults diagnosed with cancer face decades of life after cure, during which late effects—cardiac dysfunction, secondary malignancies, infertility, endocrine problems, cognitive changes, and psychosocial distress—may emerge and progress. Research has consistently shown that this age group experiences unique biology and unique psychosocial burdens, and that their survival gains have historically lagged behind those of children and older adults. Survivorship clinics are designed to catch these late effects early, coordinate surveillance, and connect survivors with interventions. When fewer than five percent of eligible survivors walk through the clinic door, the potential of that model goes largely unrealized, and preventable morbidity may accumulate silently for years.

The implications drawn by the authors are pointed. Lack of awareness of the survivorship clinic was the most significant barrier, and a referral from their oncology care team would have facilitated them scheduling a visit. This suggests a relatively low-cost, high-impact intervention: embedding an explicit survivorship referral into the standard end-of-treatment workflow, paired with clear patient-facing information about what the clinic offers and telehealth options to reduce logistical friction. The study’s connection to the INSPIRE digital health trial also hints at a broader strategy—meeting young survivors where they already are, on their phones, rather than waiting for them to find a clinic they have never heard of. As health systems implement national survivorship standards, the lesson of this study is that building clinics is only half the task; the other half is making sure the patients who need them know they exist.

For survivors themselves, the message is equally practical: late effects are real, monitoring is worthwhile, and help is available beyond the end of treatment. For oncology teams, the message is that the handoff from active treatment to survivorship care cannot be left to chance. A single sentence from a trusted oncologist—a referral, an explanation, an invitation—may be the difference between a young survivor who falls through the cracks and one who receives the long-term surveillance that modern cancer care promises. With 4.5 percent utilization as the baseline, there is enormous room for improvement, and this study offers a clear, evidence-based map of where to begin.

Subject of Research: Utilization of survivorship clinics by adolescent and young adult cancer survivors

Article Title: A mixed methods study of adolescent and young adult cancer survivors and their utilization of a survivorship clinic: Barriers and facilitators

Article References: Yi, J. C., Ballard, S., Artim, E. J., Walsh, C., & Baker, K. S. (2026). A mixed methods study of adolescent and young adult cancer survivors and their utilization of a survivorship clinic: Barriers and facilitators. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-026-02125-y

Image Credits: AI Generated

DOI: 10.1007/s11764-026-02125-y

Keywords: adolescent and young adult oncology, cancer survivorship, survivorship clinic, late effects, mixed methods, qualitative interviews, telehealth, health care utilization, barriers and facilitators, cancer survivorship care standards, Fred Hutchinson Cancer Center, digital health intervention

Each year, over 80,000 individuals aged between 15 and 39 receive a cancer diagnosis, and currently, more than two million young cancer survivors reside in the United States alone. This demographic faces a complex constellation of issues as they transition from treatment to survivorship. Unlike pediatric or older adult cancer patients, AYAs confront a distinct set of psychosocial and physiological stressors, including the interruption of critical life milestones such as educational advancement, career initiation, and family planning. Their post-treatment landscape is shaped both by the biological repercussions of the disease and its treatment, and by the broader societal ramifications of their experience.

Leading this ambitious endeavor is Dr. Shoshana Rosenberg, an associate professor of population health sciences at Weill Cornell Medicine. Dr. Rosenberg emphasizes the pressing need to understand the particular needs of young survivors, which diverge substantially from those of other age groups. The study seeks to garner direct insights from patients to inform and refine clinical care delivery. By focusing on patient-reported experiences and real-world outcomes, the research aims to translate these findings into more empathetic and effective healthcare strategies tailored for the AYA population.

Central to the study’s methodology is the creation of a meticulously assembled cohort of 2,000 adolescent and young adult cancer survivors located in New York City. This diverse cohort will be monitored longitudinally to evaluate both immediate and delayed consequences of novel therapeutic approaches, including biological agents and immunotherapies now increasingly prominent in oncology. Unlike traditional chemotherapy and radiation, these newer treatments have complex profiles regarding long-term toxicity and survivorship outcomes. Documenting these effects will provide critical data to delineate survivorship patterns unique to modern treatment paradigms.

One distinctive aspect of this research is its comprehensive approach to the myriad challenges AYAs face post-treatment. The study places considerable emphasis on sensitive yet consequential issues such as fertility preservation and sexual health, acknowledging that cancer and its treatments can profoundly impact reproductive potential and intimacy. In tandem, the financial burdens incurred by young survivors are also scrutinized, recognizing that the economic strain of cancer care can exacerbate psychological distress and hinder access to follow-up services. By addressing these interconnected domains, the research fosters a holistic understanding of survivorship.

The project deploys an innovative mobile application designed expressly for this digitally adept generation to facilitate seamless communication between researchers and participants. This app will enable survivors to regularly complete surveys and provide health updates over the study period. Moreover, it is equipped to collect sensor-derived data related to physical activity and sleep patterns, delivering an unprecedented window into daily functioning and overall well-being through passive monitoring. This multi-modal data collection promises to enrich the characterization of health trajectories following cancer treatment.

Beyond patient self-report and passive sensor data, the study integrates biological sample collection and access to electronic medical records (EMRs). Leveraging EMRs allows for real-time clinical data assimilation, including lab results and treatment history, strengthening the robustness of longitudinal analyses. Biological samples may aid in identifying biomarkers predictive of late-onset complications, offering the tantalizing possibility of preemptive interventions. Such integrative data strategies exemplify the movement toward precision medicine in oncology survivorship, aiming to tailor supportive care based on individual risk profiles.

An equally important goal of the project is to translate findings into actionable interventions that can preempt or mitigate adverse long-term health outcomes. By identifying risk factors for sequelae such as cardiotoxicity, secondary malignancies, or psychological distress, the research hopes to enable earlier clinical interventions. Furthermore, the study seeks to dismantle barriers of accessibility to supportive care services, enhancing equity in survivorship care for AYAs from diverse socioeconomic and cultural backgrounds. The intention is to promote not only survival but quality of life and functional recovery.

The mobile platform also holds potential beyond data collection—serving as a conduit for disseminating supportive care resources and fostering a sense of community among participants. Social isolation is a common and often overlooked plight for young survivors, and digital connectivity can offer critical psychosocial support. By creating virtual spaces for peer engagement and information exchange, the study envisions reinforcement of resilience and empowerment. This approach aligns with emerging trends in digital health interventions aimed at chronic disease management and mental health support.

Dr. Rosenberg expresses hope that this pioneering research will illuminate previously unanswered questions surrounding the AYA cancer survivor experience. The study is poised to inform communication strategies between healthcare providers and patients, ensuring that the unique concerns of young survivors are acknowledged and addressed effectively throughout the continuum of care. Improving dialogue and understanding within clinical encounters is fundamental to fostering shared decision-making and personalized survivorship planning.

Joining Dr. Rosenberg are co-principal investigators Dr. Danielle Friedman, an attending physician at Memorial Sloan Kettering Cancer Center, and Dr. Jeanine Genkinger, an associate professor of epidemiology at Columbia University Mailman School of Public Health. Their combined expertise in clinical oncology, epidemiology, and population health sciences bolsters the interdisciplinary nature of this comprehensive research initiative. Together, the team aims to bridge gaps between clinical research and practical support mechanisms for AYAs battling the sequelae of cancer and its treatment.

This study reflects a broader paradigm shift in oncology, moving from a sole focus on disease eradication toward a more nuanced understanding of survivorship and quality of life. By harnessing cutting-edge technology and cross-disciplinary collaboration, the project exemplifies future directions for cancer research and care delivery. The integration of patient engagement, digital health tools, biomarker discovery, and social determinants of health marks an important evolution in addressing the needs of historically overlooked populations.

Ultimately, the funding and research efforts spearheaded by Weill Cornell Medicine and collaborators aspire to create a replicable model for AYA cancer survivorship care. Insights garnered from this New York City cohort could catalyze policy changes, guide healthcare infrastructure development, and inspire similar studies nationally and globally. As survival rates improve across cancer types, the imperative to optimize long-term outcomes and holistic well-being for young survivors stands as a defining challenge—and opportunity—of modern oncology.

Subject of Research: Adolescent and Young Adult (AYA) Cancer Survivorship and Supportive Care Development

Article Title: Innovative Research Unveils the Hidden Struggles of Young Cancer Survivors: A Five-Year Study at Weill Cornell Medicine

News Publication Date: Not specified

Web References:

• Dr. Shoshana Rosenberg’s Faculty Profile, Weill Cornell
• Dr. Danielle Friedman, Memorial Sloan Kettering Cancer Center
• Dr. Jeanine Genkinger, Columbia University Mailman School of Public Health

Image Credits: Weill Cornell Medicine

Keywords: Cancer, Adolescent and Young Adult Survivors, Cancer Survivorship, Immunotherapy, Biological Treatments, Long-term Effects, Fertility Concerns, Financial Stress, Digital Health, Mobile Applications, Biomarkers, Supportive Care, Patient-Centered Research